Search results
Pilot Study in JNCCN Explores New Approach for Reducing Anxiety and Improving Quality of Life after ...
Morning Times· 3 days agoPLYMOUTH MEETING, Pa., June 11, 2024 /PRNewswire/ -- New research in the June 2024 issue of JNCCN—Journal of the National Comprehensive ...alleviating distress, enhancing ...
Inside the Human Brain: Genetic Discoveries That Could Revolutionize Medicine
SciTechDaily· 2 days agoNew study could improve the ability to make genetic diagnoses and treat neurodevelopmental...
Towards molecular and phenotypic characterization of VEXAS syndrome
Medical Xpress· 1 day agoVEXAS syndrome is a rare, adult-onset, life-threatening autoinflammatory disease caused by a genetic...
Unraveling the mystery of atherosclerosis in patients with Werner syndrome
Medical Xpress· 2 days agoThe mutation in the WRN gene causes a rare genetic disease known as Werner syndrome (WS). Since the affected cells cannot repair DNA damage correctly, patients with WS undergo accelerated aging ...
The Last Trace of Sam Bankman-Fried’s Political Ambitions
Politico via Yahoo Finance· 3 days agoThe Bankman-Fried brothers enlisted a tech executive-turned-effective altruist named Max Henderson and Anna Maybach Sullivan, a former medical researcher who had worked to ...
What Will the Next 30 Years of Beauty Look Like?
InStyle via Yahoo News· 2 days agoPaul Jarrod Frank, M.D., a New York-based celebrity dermatologist, predicts a groundswell of research around regenerative medicine, exosomes, and stem...
Open access is working — but researchers in lower-income countries enjoy fewer benefits
Nature· 3 days agoDeep-seated aspects of local research systems need to be uprooted to ensure that researchers in...
Coping With Graft-Versus-Host-Disease
Verywell Health via Yahoo News· 3 days agoLearn how to cope with your graft-versus-host-disease day-to-day, including how to eat to reduce symptoms, exercise, manage finances, and find support.
Geron Co. (NASDAQ:GERN) Receives Consensus Rating of “Moderate Buy” from Brokerages
ETF DAILY NEWS· 4 days agoOne analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year target price among analysts that have issued a report on the stock in ...
Scientists get a new tool to study a common genetic heart condition
Axios· 5 days agoWhy it matters: Hypertrophic cardiomyopathy (HCM) — which affects an estimated 600,000 to 1.5...